Skip to main content

COVID-19 Topic Center

Interactive Features

First Report Managed Care
In this episode of PopHealth Perspectives,  Kiersten Combs, vice president, US Cardiovascular and Metabolic Disease (US CVMD) and Naeem Khan, MD, vice president, medical, US CVMD, AstraZeneca, discuss the recent approval of Farxiga (dapagliflozin), and explain how this treatment lowers the…
First Report Managed Care
Robert Giugliano, MD, cardiovascular medicine specialist at Brigham and Women's Hospital, discusses the results of the ENGAGE AF-TIMI 48 trial explaining the benefits of treating patients with edoxaban, and why he encourages health care professionals to get to know all of the available NOACs.
Back to Top